鲁南制药集团股份有限公司

鲁南制药集团是集中药、西药、生物制药的生产、科研、销售于一体的国家大型综合制药集团、国家重点高新技术企业,成员企业包括鲁南厚普制药有限公司、鲁南贝特制药有限公司、山东新时代药业有限公司、鲁南新时代医药有限公司等八家子公司,位列中国大企业集团竞争力500强,连续七

年荣登山东省纳税100强榜。

    

鲁南制药集团重视科技创新,设有国家手性制药工程技术研究中心、哺乳动物细胞高效表达国家工程实验室、中药制药共性技术国家重点实验室、国家级企业技术中心、博士后科研工作站、“泰山学者”岗位等科研平台。在加强自主创新体系建设的同时,企业与100余所国内外知名院所建立了长期合作关系,成功地完成了400多项研究课题,多次承担国家科技支撑计划、国家863计划、国家重大新药创制专项、国家火炬计划、国家重点新产品计划,100多个项目获得科技奖项,其中国家科技进步二等奖6项。近年来已申报国际、国内发明专利900多项,已获授权专利500多项,荣获“国家技术创新示范企业”、“国家创新型企业”等称号,集团科技创新能力居全国同行业前列。

 

鲁南制药集团始终坚持“造福社会,创造美好生活”的经营宗旨,秉承“不怕困难、挑战困难、战胜困难”的企业精神,坚持“以改革为动力、以市场为中心、以科技为先导”的指导思想,企业从19万元净资产、2万元贷款起步,由一个濒临倒闭的校办小厂发展成为国家大型综合制药集团,被授予“全国五一劳动奖状”、“全国模范职工之家”、“全国群众体育先进单位”等称号。  

 

风华正茂、立志全球的鲁南制药集团正以“保持化学制药的优势,大力发展中药,做强生物制药”为目标,在为成为国内领先、世界一流的国际化综合制药集团而不懈奋斗!

 


Lunan Pharmaceutical Group Corporation is a major national hi-tech enterprise and National Key High New Technology Enterprise that produces, researches and sells both traditional Chinese medicine, chemical medicine and bio-pharmaceutical medicinal products.

 

The group is comprised of eight subsidiary companies including Lunan Hope Pharmaceutical Co., LTD., Lunan Better Pharmaceutical Co., LTD., Shandong New Time Pharmaceutical Co., LTD., Lunan New Time Bio-Tech Co., LTD. etc.. It is an energetic and potential enterprise that has more than 9000 employees with an average age of 30 and 80% graduated form colleges. In 2015, the total sale revenues reached 1.1 billion dollars.

The group is equipped with National China Pharmaceutical Engineering Technology Research center, National Mammalian Cells Efficiently Express Engineering Laboratory, New Technology of TCM State Key Lab, National Enterprise Technology center, Postdoctoral Scientific Research workstation, Biological Pharmaceutical Industry Technology center of Shandong and Mount Taishan Scholars Post. It was selected into the top 500 enterprises of China in two consecutive years, Shandong top 100 taxpayer in four consecutive years, awarded Shandong Advanced tax payer by the government.

 

Science and technology are the primary productive force and independent innovation is the first competitive force. The group builds its own research teams. Meanwhile collaborated with East-China University of Science and Technology, Luhua Biotechnology Research Institute was set up. And then collaborated with Shandong University, the supercritical fluid technology research institute and the natural drug research academy were set up. It has built a long partnership with some internationally renowned institutes in Italy and Rumania, with more than 80 domestic famous institutes like Shandong University. In recent years, the company has finished more than 300 research subjects, including more than 50 items of plan such as National Science and Technology Support Plan, National 863 Plan, National Key New Drugs Special Formulate, National Torch Project, National Key Product Plan. The company has 80 products authenticated by experts, 30 ones reached to the advanced international standards, 43 ones leading in the country, more than 80 subjects received Science and Technology Progress Award, including National Technology Invention Second Prize 1, National Scientific and Technological Progress Second Prize 6, Provincial Science and Technology Award 21. In recent years, the company has declared 957 international or domestic invention patents (26 PCT patents) and 546 passed, the quantity of the issued patent ranks the first among domestic pharmaceutical enterprises, being awarded the title of “the First Domestic Top Ten Enterprise with Best Product Line”. The company has registered 2100 trademarks and got 1485 certificates, “Lunan” trade mark was approved “Famous Trademark of China” by SAIC in 2006. (Data revision until Jun. 2016)

 

With the goal of “Keep the advantage of chemical pharmaceutical industry, strive to develop traditional Chinese medicine, make biological pharmacy stronger”, Lunan Pharmaceutical Group Corporation will turn into a large-scale, comprehensive, leading domestic level, world class pharmaceutical research and manufacturing base. It moves forward to a multi-national group corporation in big strides.